Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026)
Bausch Health Companies (BHC) posted Total Current Liabilities of $4.5 billion for Q2 2026, little changed sequentially from $4.5 billion in Q1 2026, and down 8.66% YoY from $5.0 billion in Q2 2025.
Bausch Health Companies (BHC) Total Current Liabilities (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Total Current Liabilities for 18 years, with the latest figure at $4.5 billion in Q2 2026.
- Quarterly Total Current Liabilities fell 8.66% year-over-year to $4.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.5 billion (down 8.66% YoY) and the FY2025 annual result came in at $4.2 billion, down 38.09% from the prior year.
- Total Current Liabilities steadied at $4.5 billion in Q2 2026 per BHC's latest filing, from $4.5 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $6.8 billion in Q4 2024 and troughed at $3.8 billion in Q3 2022.
- A 5-year average of $4.5 billion and a median of $4.4 billion in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 56.95% in 2024, then sank 38.09% in 2025.
- Over 5 years, Total Current Liabilities stood at $3.9 billion in 2022, then gained by 9.16% to $4.3 billion in 2023, then surged by 56.95% to $6.8 billion in 2024, then tumbled by 38.09% to $4.2 billion in 2025, then advanced by 8.71% to $4.5 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $4.5 billion, $4.5 billion, and $4.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 32.27 Bn | 30.60 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.33 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.93 Bn | 18.04 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.79 Bn |
| 10 | Bausch Health Companies | 2.47 Bn | 627.62 Mn | 2.10 Bn | 4.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.54 Bn |
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.18 Bn |
| Sep 30, 2025 | 4.79 Bn |
| Jun 30, 2025 | 4.98 Bn |
| Mar 31, 2025 | 4.26 Bn |
| Dec 31, 2024 | 6.75 Bn |
| Sep 30, 2024 | 4.51 Bn |
| Jun 30, 2024 | 4.37 Bn |
| Mar 31, 2024 | 4.41 Bn |
| Dec 31, 2023 | 4.30 Bn |
| Sep 30, 2023 | 4.22 Bn |
| Jun 30, 2023 | 3.97 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.94 Bn |
| Sep 30, 2022 | 3.83 Bn |
| Jun 30, 2022 | 5.00 Bn |
| Mar 31, 2022 | 4.77 Bn |
| Dec 31, 2021 | 5.20 Bn |
| Sep 30, 2021 | 5.44 Bn |